It is in this context, as an extracellular receptor agonist, that most effects of S1P on normal and cancer stem cells have been studied, and where S1P has been shown to have roles in mobilisation of HSCs from the bone marrow as well as regulating the differentiation of a diverse range of cells. Here, MBTPS1 is linked to cancer.